Relative comparative qRT-PCR indicated that the log2 fold change of LINC-ROR and SALL4 decreased in 55.81% (48/86) and 24.41% (21/86) of tumor samples compared to the adjacent non-cancerous tissues (p < 0.0001); however, 38 (44.18%) and 65 (75.58%) samples showed the normal or overexpression of LINC-ROR and SALL4 (P < 0.0001), respectively (Table 4). The gene discussed is SALL4; the disease is neoplasm.